Bicara Therapeutics Investor Relations Material

Bicara Therapeutics Inc. is a biopharmaceutical company focused on developing innovative immuno-oncology therapies for cancer treatment. The company specializes in creating biologics that combine tumor-targeting properties with immune modulation to improve treatment outcomes for patients with advanced or resistant cancers. Bicara’s research and development efforts are geared toward creating therapies that harness the body’s immune system to selectively target and combat cancer cells. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.